Korea License Holder: Who Holds the Korean Import Licence

1. Key takeaways

A foreign manufacturer cannot hold a Korean import item licence in its own name. The applicant for an import item licence must be a legally registered entity in Korea (Korea License Holder, KLH), which submits the application, obtains the licence and holds it. The true barrier of Korean registration is not the technical dossier but the local entity: the dossier can be outsourced, the local entity cannot.

• The licence holder must simultaneously satisfy 4 eligibility conditions: a registered business premises in Korea; a dedicated quality manager; a valid import business licence; and formal registration with the Ministry of Food and Drug Safety (MFDS).
• These 4 conditions are parallel requirements. Failure of any one of them transmits directly to the licence itself, rather than affecting only a single shipment.
• The licence holder carries 6 statutory duties spanning the pre-market and post-market phases: submitting the registration application; submitting the KGMP application and supporting the on-site audit; cooperating with distributors to complete importation; coordinating incident (adverse event) reporting; acting as the primary contact for MFDS; and assisting with health insurance reimbursement applications to the Health Insurance Review and Assessment Service (HIRA).
• Because the licence holder controls the import channel, its selection and its continued qualification determine whether the entire Korean market access remains workable, not merely whether one registration file can be submitted.

2. Legal basis

The duties and eligibility conditions of the licence holder derive from the following instruments. Every conclusion in this article can be traced back to the regulation names, document numbers, publication dates and provisions listed below.

3. Expert insights

Insight 1: Holding the licence is not nominal agency, it is assumption of responsibility. Treating the KLH as merely a place to sign documents in Korea is the most expensive misjudgement available. The licence holder must support MFDS on-site audits, coordinate adverse event reporting and serve as the primary contact for MFDS, and all three of these duties continue throughout the post-market phase. Even if a foreign manufacturer keeps manufacturing and distribution entirely in its own hands, it cannot bypass the direct interface between the licence holder and the regulator. When GRZAN assesses whether a licence holder is qualified, the test is not whether it holds a business registration certificate but whether it has the actual capability to assume all 6 duties.

Insight 2: Among the 4 eligibility conditions, the easiest to lapse is the presence of the quality manager. Business premises, the import business licence and MFDS registration are all states that are obtained once and maintained over time, whereas the dedicated quality manager is a person who moves. If the quality manager departs and is not replaced promptly, the licence holder formally still holds the licence but substantively no longer meets the statutory conditions. GRZAN recommends making the quality manager’s presence a continuing obligation in the licence holder agreement, with a duty to notify any change proactively, rather than waiting for it to be discovered at renewal or during an on-site audit. This point is critical because the other 3 conditions are institutional states that change rarely and can be verified once, while the personnel condition can fail at any moment as staffing changes. In annual self-inspection, companies should verify the quality manager and the licence validity on the same sheet.

Insight 3: The cost of exiting a licence holder arrangement is significantly higher than the cost of entering one. Changing the licence holder means a transfer at the licence level, not a simple change of service provider. The pattern GRZAN commonly observes is that when a company changes licence holders because of a commercial dispute, the import channel breaks at the same time, because during the transition no entity holds both the licence and import capability. This structure means the licence holder should be evaluated on a cooperation horizon of 5 years or more (the item renewal cycle), not on the scale of a single registration project.

Insight 4: Separating licence holding from distribution is a commercial arrangement, not a regulatory mandate. The Medical Devices Act does not require the licence holder to be the distributor as well. Binding both roles to one distributor removes the company’s freedom to change channels, because changing the distributor then means changing the licence holder. GRZAN prefers to separate the two roles; the detailed approach, together with the use of Identical Product Registration (IPR), is explained in a dedicated article.

4. Practical recommendations

• Verify licence holder eligibility before the technical dossier is prepared. If the licence holder is not qualified, no amount of document completeness allows the application to be filed. The checklist should cover all 4 conditions: business premises, dedicated quality manager, valid import business licence and MFDS registration.
• State performance standards and deadlines for all 6 duties in the licence holder agreement. MFDS liaison and incident reporting coordination in particular must have agreed response deadlines, to avoid a responsibility vacuum after market entry.
• Require the licence holder to report the presence status of the quality manager on a regular basis. Quarterly written confirmation is recommended, with the obligation written into the agreement.
• Select the licence holder on a 5-year cycle rather than a single-project cycle. Item renewal occurs every 5 years, and the cost of a mid-cycle exit far exceeds the extra service cost paid at the outset.
• Avoid binding licence holding and distribution into a single entity. If a distributor already exists, any assessment of its licence-holding capability must also assess the commercial constraint risk.

5. Verification checklist

• □ Licence holder business premises: verify the Korean registered business premises record; the registered address matches the actual operating address.
• □ Dedicated quality manager: verify the appointment documents and presence status; the manager is dedicated and holds no incompatible concurrent roles.
• □ Import business licence: verify validity; the licence is within its validity period and has not been suspended or revoked.
• □ MFDS registration: verify the registration record in the MFDS system; formal registration is complete and the information is accurate.
• □ Capability to assume the 6 duties: check one by one against registration application, KGMP, import cooperation, incident reporting, MFDS liaison and HIRA assistance; each duty has a named responsible person and a defined process.
• □ Agreement coverage: review the duties and deadline clauses of the licence holder agreement; all 6 duties are covered in writing.
• □ Exit and change arrangements: verify the change and handover clauses of the agreement; change triggers and transition arrangements are clearly defined.
• □ Regulatory information verified as of 29 October 2026 (pending verification for any later amendments).

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, Korean licence holder and local testing support for the Republic of Korea. Our team coordinates licence holder arrangements, import business registration, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com